BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25600439)

  • 1. Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases.
    Maker AV; Ito H; Mo Q; Weisenberg E; Qin LX; Turcotte S; Maithel S; Shia J; Blumgart L; Fong Y; Jarnagin WR; DeMatteo RP; D'Angelica MI
    Cancer Immunol Res; 2015 Apr; 3(4):380-8. PubMed ID: 25600439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases.
    Qin JZ; Upadhyay V; Prabhakar B; Maker AV
    J Transl Med; 2013 Mar; 11():70. PubMed ID: 23514280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low infiltration of peritumoral regulatory T cells predicts worse outcome following resection of colorectal liver metastases.
    Nakagawa K; Tanaka K; Homma Y; Nojiri K; Kumamoto T; Takeda K; Endo I
    Ann Surg Oncol; 2015 Jan; 22(1):180-6. PubMed ID: 25120248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High infiltration of mast cells positive to tryptase predicts worse outcome following resection of colorectal liver metastases.
    Suzuki S; Ichikawa Y; Nakagawa K; Kumamoto T; Mori R; Matsuyama R; Takeda K; Ota M; Tanaka K; Tamura T; Endo I
    BMC Cancer; 2015 Nov; 15():840. PubMed ID: 26530140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
    Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
    Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.
    Katz SC; Pillarisetty V; Bamboat ZM; Shia J; Hedvat C; Gonen M; Jarnagin W; Fong Y; Blumgart L; D'Angelica M; DeMatteo RP
    Ann Surg Oncol; 2009 Sep; 16(9):2524-30. PubMed ID: 19568816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases.
    Pikoulis E; Margonis GA; Andreatos N; Sasaki K; Angelou A; Polychronidis G; Pikouli A; Riza E; Pawlik TM; Antoniou E
    Anticancer Res; 2016 Sep; 36(9):4805-11. PubMed ID: 27630332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of laparoscopic versus open liver resection for liver metastases from colorectal cancer: A comparative analysis of 168 consecutive cases at a single center.
    Hasegawa Y; Nitta H; Sasaki A; Takahara T; Itabashi H; Katagiri H; Otsuka K; Nishizuka S; Wakabayashi G
    Surgery; 2015 Jun; 157(6):1065-72. PubMed ID: 25791030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.
    Qiao G; Qin J; Kunda N; Calata JF; Mahmud DL; Gann P; Fu YX; Rosenberg SA; Prabhakar BS; Maker AV
    Cancer Res; 2017 Apr; 77(8):1880-1891. PubMed ID: 28249900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis.
    Höppener DJ; Nierop PMH; Hof J; Sideras K; Zhou G; Visser L; Gouw ASH; de Jong KP; Sprengers D; Kwekkeboom J; Vermeulen PB; Grünhagen DJ; Verhoef C
    Br J Cancer; 2020 Jul; 123(2):196-206. PubMed ID: 32418992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
    Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY
    J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
    Liang Z; Li X
    Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating PD-L1 is associated with T cell infiltration and predicts prognosis in patients with CRLM following hepatic resection.
    Chen X; Du Z; Huang M; Wang D; Fong WP; Liang J; Fan L; Wang Y; Yang H; Chen Z; Hu M; Xu R; Li Y
    Cancer Immunol Immunother; 2022 Mar; 71(3):661-674. PubMed ID: 34322779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
    Narayanan S; Kawaguchi T; Yan L; Peng X; Qi Q; Takabe K
    Ann Surg Oncol; 2018 Aug; 25(8):2323-2331. PubMed ID: 29770915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases.
    Balachandran VP; Arora A; Gönen M; Ito H; Turcotte S; Shia J; Viale A; Snoeren N; van Hooff SR; Rinkes IH; Adam R; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
    Clin Cancer Res; 2016 May; 22(10):2575-82. PubMed ID: 26733613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases.
    Katz SC; Donkor C; Glasgow K; Pillarisetty VG; Gönen M; Espat NJ; Klimstra DS; D'Angelica MI; Allen PJ; Jarnagin W; Dematteo RP; Brennan MF; Tang LH
    HPB (Oxford); 2010 Dec; 12(10):674-83. PubMed ID: 21083792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.